Cargando…

New, Novel Lipid-Lowering Agents for Reducing Cardiovascular Risk: Beyond Statins

Mostrar otras versiones (1)

Detalles Bibliográficos
Autores principales:	Kim, Kyuho, Ginsberg, Henry N., Choi, Sung Hee
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Diabetes Association 2022
Materias:	Corrigendum
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9532179/ https://www.ncbi.nlm.nih.gov/pubmed/36193731 http://dx.doi.org/10.4093/dmj.2022.0295

Ejemplares similares

New, Novel Lipid-Lowering Agents for Reducing Cardiovascular Risk: Beyond Statins
por: Kim, Kyuho, et al.
Publicado: (2022)

Beyond Lipid-Lowering: Effects of Statins on Cardiovascular and Cerebrovascular Diseases and Cancer
por: Morofuji, Yoichi, et al.
Publicado: (2022)

Corrigendum to “Protective Effects of Simvastatin, a Lipid Lowering Agent, Against Oxidative Damage in Experimental Diabetic Rats”
por: Mohamadin, Ahmed M., et al.
Publicado: (2020)

New Drugs for Treating Dyslipidemia: Beyond Statins
por: Ahn, Chang Ho, et al.
Publicado: (2015)

Corrigendum to “Reduced Oxidative Stress Contributes to the Lipid Lowering Effects of Isoquercitrin in Free Fatty Acids Induced Hepatocytes”
por: Hassan, Waseem, et al.
Publicado: (2015)

Beyond lipid lowering: pleiotropic effects of statins in heart failure
por: Swenne, C. A.
Publicado: (2013)

Statins and the Brain: More than Lipid Lowering Agents?
por: Fracassi, Anna, et al.
Publicado: (2019)

Oral Lipid-Lowering Treatments Beyond Statins: Too Old and Outdated or Still Useful?
por: Parhofer, Klaus G.
Publicado: (2021)

Corrigendum to “TMBIM6 deficiency leads to bone loss by accelerating osteoclastogenesis” [Redox Biol. 64 (2023) 102804]
por: Yi, Sun-Ju, et al.
Publicado: (2023)

Anti-Inflammatory Effects of Statins Beyond Cholesterol Lowering
por: Joo, Seung-Jae
Publicado: (2012)

Lipid-lowering therapy using statins in patients with cardiovascular risk in clinical practice in Thailand
por: Silaruks, Songkwan, et al.
Publicado: (2011)

Potent anti-ischaemic effects of statins in chronic stable angina: incremental benefit beyond lipid lowering?
por: Deanfield, John E., et al.
Publicado: (2010)

Therapeutic implications of statins beyond lipid lowering: In the perspective of their effects on the antigen presentation, T cells and NKT cells
por: Khan, Masood Alam
Publicado: (2021)

Corrigendum to: Obesity reduces the real-world effectiveness of cytokine-targeted but not cell-targeted disease-modifying agents in rheumatoid arthritis
por: Schäfer, Martin, et al.
Publicado: (2020)

Pleiotropic and Lipid–lowering Effects of Statins in Hypertension
por: Kamberi, Lulzim Selim, et al.
Publicado: (2012)

Lipid-lowering drugs (statins) and peripheral neuropathy
por: Emad, Mohammadreza, et al.
Publicado: (2018)

Novel Uses for Lipid-Lowering Agents
por: May, Megan Brafford, et al.
Publicado: (2016)

The novel anti-neuroblastoma agent PF403, inhibits proliferation and invasion in vitro and in brain xenografts
por: Li, Chao, et al.
Publicado: (2022)

Scavenging of lipid peroxyl radicals protects plasma lipids and proteins from peroxynitrite
por: Mustafa, Ayman G, et al.
Publicado: (2020)

Effect and safety of combination lipid‐lowering therapies based on statin treatment versus statin monotherapies on patients with high risk of cardiovascular events
por: Wang, Chunli, et al.
Publicado: (2018)

Beyond the Brain: The Systemic Pathophysiological Response to Acute Ischemic Stroke
por: Balch, Maria H.H., et al.
Publicado: (2020)

Reduced Variability of Endurance Time in New Protocols for Exercise Tests in COPD [Corrigendum]
Publicado: (2021)

Corrigendum to “Autophagy induction extends lifespan and reduces lipids content in response to frataxin silencing in C. elegans” [Exp. Gerontol. 48 (2013) 191–201]
por: Schiavi, Alfonso, et al.
Publicado: (2013)

Statins in High-Risk Chronic Obstructive Pulmonary Disease Outpatients: No Impact on Time to First Exacerbation and All-Cause Mortality – The STATUETTE Cohort Study [Corrigendum]
Publicado: (2021)

Correction: Physiological Responses During the Lower Body Positive Pressure Supported Treadmill Test
por: Bang, Tae Sik, et al.
Publicado: (2016)

Statins in cardiometabolic disease: what makes pitavastatin different?
por: Ginsberg, Henry
Publicado: (2013)

Fabrication of novel vesicles of triptolide for antirheumatoid activity with reduced toxicity in vitro and in vivo [Corrigendum]
Publicado: (2019)

Glycaemic Effects of Non-statin Lipid-Lowering Therapies
por: Collins, Patrick D., et al.
Publicado: (2016)

Pleiotropic use of Statins as non-lipid-lowering drugs
por: Zhang, Qijia, et al.
Publicado: (2020)

Novel polygodial analogs P3 and P27: Efficacious therapeutic agents disrupting mitochondrial function in oral squamous cell carcinoma
por: De La Chapa, Jorge, et al.
Publicado: (2020)

Corrigendum to “Dietary Lipids in Health and Disease”
por: Amin, Kamal A., et al.
Publicado: (2020)

Efficacy of trabectedin in advanced soft tissue sarcoma: beyond lipo- and leiomyosarcoma [Corrigendum]
Publicado: (2016)

Correction: Effectiveness of Lower Energy Density Extracorporeal Shock Wave Therapy in the Early Stage of Avascular Necrosis of the Femoral Head
por: Han, Yong, et al.
Publicado: (2017)

Corrigendum to: Association between use of novel glucose-lowering drugs and COVID-19 hospitalization and death in patients with type 2 diabetes: A nationwide registry analysis
Publicado: (2023)

Lipid-Lowering Drug Effects Beyond the Cardiovascular System: Relevance for Neuropsychiatric Disorders
por: Lohoff, Falk W
Publicado: (2018)

A Cleverly Designed Novel Lipid Nanosystem: Targeted Retention, Controlled Visual Drug Release, and Cascade Amplification Therapy for Mammary Carcinoma in vitro [Corrigendum]
Publicado: (2020)

Promoter methylation of RASSF1A modulates the effect of the microtubule-targeting agent docetaxel in breast cancer
por: Gil, Eun Young, et al.
Publicado: (2017)

Corrigendum to “Cholesterol-Lowering Probiotics as Potential Biotherapeutics for Metabolic Diseases”
por: Kumar, Manoj, et al.
Publicado: (2022)

Identification of Maturity-Onset Diabetes of the Young Caused by Glucokinase Mutations Detected Using Whole-Exome Sequencing
por: Cho, Eun-Hee, et al.
Publicado: (2021)

Beyond weight loss: a review of the therapeutic uses of very-low-carbohydrate (ketogenic) diets
por: Paoli, A, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_kuj5aco8pv7j6qnk3vgn29ng8v